Dignity Talk: Helping Palliative Care Patients and Families Have Important Conversations (DTalk)

December 12, 2017 updated by: University of Manitoba

Dignity Talk: a Novel Palliative Care Intervention for Patients and Their Families

Dying patients and their families face many challenges near the end-of-life. Not only do patients often experience physical distress, but they also have feelings of loss of dignity, isolation, and uncertainty. Family members also face many challenges. They bear witness to the suffering of loved ones, and they face uncertainty, loss, and at times a mounting sense of helplessness.

The purpose of this study is to introduce and evaluate a new intervention called Dignity Talk, meant to enhance end-of-life experience for both patients and their families. Dignity Talk is based on a set of questions by which terminally ill patients and their family members can engage in meaningful conversations with each other. It is intended to lessen feelings of loss and helplessness and enhance feelings of connectedness by facilitating conversations that tap into a sense of meaning and purpose, sharing of memories, wishes, hopes, and giving guidance to those who will soon be left behind.

In Phase 1, 20 patients and family members will help finalize the method and Dignity Talk question framework (is it easy to understand, do the investigators have the right questions, and is the wording sensitive). In Phase 2 of the study the investigators will ask 100 patient-family pairs for feedback about Dignity Talk: what influence it had on their palliative care experience, whether it works well, and whether this intervention should become a regular part of palliative care. The investigators will also ask for feedback from health-care providers in both phases. We are requesting approval for an amendment to the healthcare provider feedback focus group questions. Will add those documents when they are approved.

Four to six months after the death of their loved one, the investigators will contact the family member to ask their thoughts about Dignity Talk, how it shaped their experience of their grief and bereavement.

The investigators expect that the study will show that Dignity Talk can be an effective, highly accessible palliative care intervention, which will enhance the end-of-life experience for palliative patients and the families who support them.

Study Overview

Detailed Description

See above summary

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Victoria, British Columbia, Canada
        • Victoria Hospice
    • Manitoba
      • Winnipeg, Manitoba, Canada
        • Concordia Hospital
      • Winnipeg, Manitoba, Canada
        • Health Sciences Centre
      • Winnipeg, Manitoba, Canada, R3E 0V9
        • St. Boniface Hospital
      • Winnipeg, Manitoba, Canada, R3L 2P4
        • Riverview Health Centre
      • Winnipeg, Manitoba, Canada
        • Deer Lodge Centre
      • Winnipeg, Manitoba, Canada
        • Grace Hospital
      • Winnipeg, Manitoba, Canada
        • Manitoba Renal Program
      • Winnipeg, Manitoba, Canada
        • Seven Oaks Hospital
      • Winnipeg, Manitoba, Canada
        • Victoria Hospital
      • Winnipeg, Manitoba, Canada
        • Winnipeg Regional Health Authority
      • Winnipeg, Manitoba, Canada
        • WRHA Personal Care Homes
    • Ontario
      • Hamilton, Ontario, Canada, L9B 1B1
        • Dr. Bob Kemp Hospice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

For Patient:

Patients being cared for:

  • in a palliative care unit or whose care is focused on palliation as determined by clinical staff
  • or patients who have have a confirmed diagnosis of amyotropic lateral sclerosis, and have symptoms in a domain that interferes with their social or occupation functioning: a) mobility, b) dysphasia, c) dyspnea, or d) speech or patients who have are have been on dialysis > 3 months and are > 60 years of age - or residents of Personal Care Home all of whom are:
  • 18 years of age or older
  • able to provide informed oral and written consent
  • cognitive capacity (based on clinical consensus)

For Family Member or Close Friend:

  • Family member or close friend who the patient identifies they would be comfortable talking with using the Dignity Talk question framework
  • Family member who is 18 years of age or older
  • Family member who is able to provide oral and written consent
  • Family member who has cognitive capacity to participate in meaningful conversation (based on research staff decision)

For Healthcare Provider:

  • Employed one of the participating sites
  • in a discipline directly involved in clinical care (physician, nursing, social work, spiritual care, allied healthcare, etc.)

Exclusion Criteria:

  • not meeting the above inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dignity Talk dyad completers
Those dyads where both patient and family member co-participant complete the protocol using the Dignity Talk Communication Topics
Patient and family member participants will be given the Dignity Talk framework questions and asked to use them in conversation with each other. Research nurse will return at day 4-6 to confirm both participants have covered all items they wish to discuss. 4-6 months after the death of patient, family members will be contacted in order to collect data pertaining to their bereavement experiences and distress. Will also be asked to complete evaluative feedback on Dignity Talk.
Experimental: Dignity Talk non-completers
Those dyads where patient and family member co-participant either do not complete the protocol or do not use the Dignity Talk Communication Topics (November 2016 - the investigators have not as yet enrolled any participants who have not completed the study without using the Dignity Talk Topics. However some participants have withdrawn from the study without completing.
There have not been any non-completers - this arm not being used currently

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Family communication connectedness Index
Time Frame: 31 months
31 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time Frame: 31 months
31 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

September 30, 2017

Study Completion (Actual)

October 31, 2017

Study Registration Dates

First Submitted

February 11, 2013

First Submitted That Met QC Criteria

June 18, 2013

First Posted (Estimate)

June 21, 2013

Study Record Updates

Last Update Posted (Actual)

December 14, 2017

Last Update Submitted That Met QC Criteria

December 12, 2017

Last Verified

November 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H2013:024

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Palliative Care

Clinical Trials on Dignity Talk

3
Subscribe